831 related articles for article (PubMed ID: 33052231)
1. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
[No Abstract] [Full Text] [Related]
2. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma.
Yuan X; Li Y; Zhang AZ; Jiang CH; Li FP; Xie YF; Li JF; Liang WH; Zhang HJ; Liu CX; Pang LJ; Shen XH; Li F; Hu JM
Aging (Albany NY); 2020 Dec; 13(2):2049-2072. PubMed ID: 33323552
[TBL] [Abstract][Full Text] [Related]
4. Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase.
Mai S; Liu L; Jiang J; Ren P; Diao D; Wang H; Cai K
Cell Prolif; 2021 Feb; 54(2):e12960. PubMed ID: 33305406
[TBL] [Abstract][Full Text] [Related]
5. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated Fibroblast-promoted LncRNA
Zhang H; Hua Y; Jiang Z; Yue J; Shi M; Zhen X; Zhang X; Yang L; Zhou R; Wu S
Clin Cancer Res; 2019 Mar; 25(6):1989-2000. PubMed ID: 30463848
[TBL] [Abstract][Full Text] [Related]
7. Homeobox A7 promotes esophageal squamous cell carcinoma progression through C-C motif chemokine ligand 2-mediated tumor-associated macrophage recruitment.
Feng A; He L; Jiang J; Chu Y; Zhang Z; Fang K; Wang Z; Li Z; Sun M; Zhao Z; Shi J; Zhang L; Chen T; Xu M
Cancer Sci; 2023 Aug; 114(8):3270-3286. PubMed ID: 37248653
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization.
Guo H; Shu J; Hu G; Liu B; Li J; Sun J; Wang X; Liu H; Xiong S; Tang Y; Yin Y; Wang X
PLoS One; 2024; 19(5):e0302780. PubMed ID: 38713738
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
10. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma.
Gopalan V; Islam F; Pillai S; Tang JC; Tong DK; Law S; Chan KW; Lam AK
Exp Cell Res; 2016 Nov; 348(2):146-154. PubMed ID: 27658568
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K
Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443
[TBL] [Abstract][Full Text] [Related]
13. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
15. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma.
Sui X; Chen C; Zhou X; Wen X; Shi C; Chen G; Liu J; He Z; Yao Y; Li Y; Gao Y
J Exp Clin Cancer Res; 2023 Feb; 42(1):51. PubMed ID: 36850011
[TBL] [Abstract][Full Text] [Related]
16. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
17. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
19. PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment.
Shi JJ; Xing H; Wang YX; Zhang X; Zhan QM; Geng MY; Ding J; Meng LH
Cancer Lett; 2019 Sep; 459():145-155. PubMed ID: 31173854
[TBL] [Abstract][Full Text] [Related]
20. CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Chen YZ; Li SG; Zou H; Pang LJ; Liu CX; Cui XB; Yang L; Zhao J; Shen XH; Jiang JF; Liang WH; Yuan XL; Li F
Oncotarget; 2017 Mar; 8(13):21526-21538. PubMed ID: 28423526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
